Downloads
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is characterized by multiple systemic comorbidities, not only airflow limitation. Metabolic syndrome (MetS) is a common comorbidity. Patients with COPD have a higher risk of MetS than do healthy individuals. Objective: (1). To determine the prevalence of metabolic syndrome in male patients with chronic obstract pulmonary disease. (2). To investigate the factors associated with metabolic syndrome in male patients with chronic obstract pulmonary disease.
Methods: A cross-sectional study in 61 male patients with a history of COPD wwho are hospitalized because of an acute exacerbation of this disease and treated stably at the Department of Endocrinology - Neurology - Respiratory Medicine, Hue Central Hospital. After that, the patients had respiratory function measured and bronchial recovery tested to reconfirm the diagnosis.
Results: The incidence of MS was 47.5%,and the proportion of groups with increased waist circumference, increased triglycerides, decreased HDL-C, increased blood pressure and increased blood glucose were 49.2%, 21.3%, 8.2%, 67.2 and 78.7% in the study population respectively. The factors age, BMI, smoking, time of disease detection, number of exacerbations in the year, CAT score are related to MS, and no factor is independently associated with MS.
Conclusion: The presence of MS is common in male COPD patients. Therefore, this group should be considered for screening for MS.
References
Cebron Lipovec N BR, van den Borst B, Doehner W, Lainscak M, Schols WJ. The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2016; 13(3).399 - 406.
WOUTERS EF. Obesity and metabolic abnormalities in chronic obstructive pulmonary disease: Annals of the American Thoracic Society. 2017; 14.Supplement 5.389-S394.
Baffi CW, Wood, L., Winnica, D., Strollo Jr, P. J., Gladwin, M. T., Que, L. G., & Holguin, F. Metabolic syndrome and the lung: Chest. 2016; 149(6).1525–1534.
Keeratichananont W, Kaenmuang, P., Geater, S. L., Manoret, P., & Thanapattaraborisuth, B. Prevalence, associated factors, and clinical consequences of metabolic syndrome in chronic obstructive pulmonary disease patients: a 5-year prospective observational study: Therapeutic Advances in Respiratory Disease. 2023; 17, 17534666231167342.
Global Initiative for Chronic Obstructive Lung Disease, Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, 2022.
Alberti KG, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity: Circulation. 2009; 120(16).1640-5.
Global Initiative for Chronic Obstructive Lung Disease, Global strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, 2014.
Breyer MK, Spruit, M. A., Hanson, C. K., Franssen, F. M., Vanfleteren, L. E., Groenen, M. T., ... & Rutten, E. P. Prevalence of metabolic syndrome in COPD patients and its consequences: PloS one. 2014; 9(6), e98013.
Tanni SE, Zamuner, A. T., Coelho, L. S., Vale, S. A., Godoy, I., & Paiva, S. A. Are metabolic syndrome and its components associated with 5-year mortality in chronic obstructive pupmonary disease patients?: Metabolic Syndrome and Related Disorders. 2015; 13(1).52-54.
Ghatas T. The relationship between metabolic syndrome and chronic obstructive pulmonary disease: Egyptian Journal of Bronchology. 2017; 11.11-15.
Piazzolla G, Castrovilli, A., Liotino, V., Vulpi, M. R., Fanelli, M., Mazzocca, A., ... & Tortorella, C. Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D: PloS one. 2017; 12(10), e0186708.
Sahoo KC, Subhankar, S., Mohanta, P. C., Jagaty, S. K., Dutta, P., & Pothal, S. Prevalence of metabolic syndrome in chronic obstructive pulmonary disease and its correlation with severity of disease: Journal of Family Medicine and Primary Care. 2022; 11(5).2094-2098.
Saltiel AR, & Olefsky, J. M. Inflammatory mechanisms linking obesity and metabolic disease: The Journal of clinical investigation. 2017; 127(1).1-4.
Chan SM, Selemidis, S., Bozinovski, S., & Vlahos, R. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies: Pharmacology & therapeutics. 2019; 198.160-188.
Minas M, Kostikas, K., Papaioannou, A. I., Mystridou, P., Karetsi, E., Georgoulias, P., ... & Gourgoulianis, K. I. The association of metabolic syndrome with adipose tissue hormones and insulin resistance in patients with COPD without co-morbidities. COPD: Journal of Chronic Obstructive Pulmonary Disease. 2011; 8(6).414-420.
Franssen FM, & Rochester, C. L. Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter?: European Respiratory Review. 2014; 23(131).131-141.
Tian Y, Liu, L., Li, Y., Fan, X., Wu, W., Shi, Y., ... & Xu, C. The impact of metabolic overweight/obesity phenotypes on unplanned readmission risk in patients with COPD: a retrospective cohort study: Frontiers in Physiology. 2023; 14, 1290611.
TIWARI A, PIRUWA, S., AGRAWAAL, S., SRIVASTAVA, G., & ShAh, D. Prevalence of Metabolic Syndrome in Chronic Obstructive Pulmonary Disease in Rural Population of Developing Country-A Cross-sectional Study: Journal of Clinical & Diagnostic Research. 2021: 15(3).
Inal-Ince D, Savci, S., Saglam, M., Arikan, H., Calik, E., Vardar-Yagli, N., ... & Coplu, L. Predictors of physical inactivity in elderly patients with chronic obstructive pulmonary disease: International Journal of Gerontology. 2014; 8(4).193-196.
Mekov E, Slavova, Y., Tsakova, A., Genova, M., Kostadinov, D., Minchev, D., & Marinova, D. Metabolic syndrome in hospitalized patients with chronic obstructive pulmonary disease: PeerJ. 2015; 3, e1068.
| Published | 24-11-2024 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | Vol. 16 No. 7 (2024) | |
| Section | Original article | |
| DOI | 10.38103/jcmhch.16.7.7 | |
| Keywords | Hội chứng chuyển hóa, Bệnh phổi tắc nghẽn mạn tính Metabolic syndrome, chronic obstructive pulmonary disease |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2024 Journal of Clinical Medicine Hue Central Hospital